Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Short Communication Volume 4 Issue 12

AIDS and Sexual Transmission of HIV: Vaginal Liquid with a pH of 2.8-4.2 Protects Women's Health as a Natural Antiseptic

Aleksandr L Urakov1*, Natalya A Urakova2, Anastasia P Stolyarenko3, Darya O Suntsova3, Ilnur I Yagudin3, Nikita M Muhutdinov3 and Varvara V Sokolova3

1DM, Professor, Head of the Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Izhevsk, Russia
2PhD, Associate Professor of the Department of Obstetrics and Gynecology, Izhevsk State Medical Academy, Izhevsk, Russia
3Student of Izhevsk State Medical Academy, Izhevsk, Russia

*Corresponding Author: Aleksandr L Urakov, DM, Professor, Head of the Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Izhevsk, Russia.

Received: November 14, 2022; Published: November 21, 2022

HIV continues to be a serious global public health problem, with 40.1 million [33.6-48.6 million] deaths to date [1]. Yet according to the World Health Organization (WHO), there is no cure for HIV. By all accounts, sexual contact with an infected partner is the most likely cause of infection [2-4]. A woman can acquire HIV from her sexual partner through blood, semen or vaginal secretions [4,5].


  1. World Health Organization. “HIV/AIDS”. (2022).
  2. Kapustin DV., et al. “New aspects of the etiology and pathogenesis of HIV infection (literature review)”. Journal of Siberian Medical Sciences 1 (2021): 92-104.
  3. Wang Z., et al. “Trace the history of HIV and predict its future through genetic sequences”. Tropical Medicine and Infectious Disease8 (2022): 190.
  4. Vardavas R and Blower S. “The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?". PLoS One1 (2007): e152.
  5. Peterman TA., et al. “Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections”. JAMA 1 (1988): 55-58.
  6. Suligoi B., et al. “The epidemic of HIV infection and AIDS, promotion of testing, and innovative strategies”. Annali dell'Istituto Superiore di Sanita1 (2010): 15-23.
  7. Kawana R., et al. “Inactivation of human viruses by povidone-iodine in comparison with other antiseptics”. Dermatology (Basel, Switzerland) 195 (1997): 29-35.
  8. Frank S., et al. “Povidone-iodine use in sinonasal and oral cavities: A review of safety in the COVID-19 era”. Ear, Nose, Throat Journal9 (2020): 586-593.
  9. Urakov AL and Shabanov PD. “Acute respiratory syndrome-2 (SARS-CoV-2): A solution of hydrogen peroxide and sodium bicarbonate as an expectorant for recanalization of the respiratory tract and blood oxygenation in respiratory obstruction (review)”. Reviews on Clinical Pharmacology and Drug Therapy 4 (2021): 383-393.
  10. Urakov АL and Urakova NA. “COVID-19: intrapulmonary injection of hydrogen peroxide solution eliminates hypoxia and normalizes respiratory biomechanics”. Russian Journal of Biomechanics4 (2021): 350-356.
  11. Fisher E., et al. “COVID-19: intrapulmonary alkaline hydrogen peroxide can immediately increase blood oxygenation”. MEDICINSKI ČASOPIS 4 (2021): 135-138.
  12. Abdool Karim Q., et al. “Preventing HIV infection in women: a global health imperative”. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 50 (2010): S122-S129.
  13. GBD 2019 Tuberculosis Collaborators. “Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019”. The Lancet Infectious Diseases2 (2022): 222-241.
  14. Lan CW., et al. “Alcohol and sexual risk reduction interventions among people living in Russia: a systematic review and meta-analysis”. AIDS and Behavior10 (2014): 1835-1846.
  15. Guinan ME and Leviton L. “Prevention of HIV infection in women: overcoming barriers”. Journal of the American Medical Women's Association.19723-4 (1995): 74-77.
  16. Naziri H., et al. “Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014”. Archives of Virology9 (2016): 2503-2509.
  17. Liu Z., et al. “Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex”. Biochemical and Biophysical Research Communications 2 (2013): 232-238.
  18. Kampf G. “Efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses”. The Journal of Hospital Infection 127 (2022): 101-110.
  19. Fadaei A. “Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants”. The Scientific World Journal (2021): 9342748.
  20. Kampf G., et al. “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents”. The Journal of Hospital Infection3 (2020): 246-251.
  21. Urakov A., et al. “Post-injection complications. Nicolau syndrome as a consequence of local irritant effects of drugs, including antiseptics, local anesthetics, NSAIDs, steroids and anticoagulants”. Journal of Pharmaceutical Research International 33A (2022): 26-36.
  22. Urakov AL. “Nikolau syndrome: Necrotic activity of drugs and ways to prevent post-injection abscesses (In memory of Professor László A Gömze)”. Creative Surgery and Oncology2 (2022): 159-163.
  23. Katzung B and Trevor A. “Basic and Clinical Pharmacology”. 15th (2020).
  24. Bodduluri VP., et al. “Physico-chemical properties of antiseptics in surgery: What is not taken into account in treating long-term non-healing wounds”. Creative Surgery and Oncology3 (2021): 256-259.
  25. Ravel J., et al. “Vaginal microbiome of reproductive-age women”. Proceedings of the National Academy of Sciences of the United States of America1 (2011): 4680-4687.
  26. Ng K., et al. “In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: a systematic review”. Human Reproduction Update1 (2018): 15-34.
  27. O'Hanlon DE., et al. “Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota”. PloS One11 (2013): e80074.
  28. O'Hanlon DE., et al. “Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration”. BMC Microbiology 1 (2019): 13.
  29. Boskey ER., et al. “Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source”. Human Reproduction (Oxford, England) 9 (2001): 1809-1813.
  30. Lykke MR., et al. “Vaginal, cervical and uterine pH in women with normal and abnormal vaginal microbiota”. Pathogens (Basel, Switzerland) 2 (2021): 90.


Citation: Aleksandr L Urakov., et al. “AIDS and Sexual Transmission of HIV: Vaginal Liquid with a pH of 2.8-4.2 Protects Women's Health as a Natural Antiseptic". Acta Scientific Women's Health 4.12 (2022): 35-39.


Copyright: © 2022 Aleksandr L Urakov., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US